Tong Yang Life Insurance Co., Ltd. (KRX:082640)
South Korea · Delayed Price · Currency is KRW 8,250.00
-20.00 (-0.24%)
Last updated: Apr 29, 2026, 2:05 PM KST
Tong Yang Life Insurance Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 1,279,800 | 1,241,272 | 1,132,353 | 1,041,462 | 4,372,779 |
Total Interest & Dividend Income | 1,087,665 | 1,006,060 | 930,431 | 1,013,397 | 955,920 |
Gain (Loss) on Sale of Investments | 731,020 | 441,197 | 594,892 | 144,852 | 297,966 |
Other Revenue | 145,681 | 80,643 | 370,832 | 360,282 | 54,994 |
| 3,244,166 | 2,769,172 | 3,028,509 | 2,559,993 | 5,681,660 | |
Revenue Growth (YoY) | 17.15% | -8.56% | 18.30% | -54.94% | -14.46% |
Policy Benefits | 2,393,663 | 1,838,051 | 1,957,821 | 1,602,612 | 4,360,678 |
Policy Acquisition & Underwriting Costs | 1,462 | 1,538 | 636 | 388 | 389,215 |
Amortization of Goodwill & Intangibles | 7,202 | 7,357 | 7,249 | 6,594 | 5,577 |
Depreciation & Amortization | 4,288 | 4,281 | 2,345 | 2,244 | 16,129 |
Selling, General & Administrative | 19,337 | 18,164 | 87,394 | 69,316 | 101,805 |
Other Operating Expenses | 382,137 | 710,529 | 378,578 | 668,334 | 130,425 |
Reinsurance Income or Expense | -20,959 | -41,346 | -17,954 | -17,515 | -84,037 |
Total Operating Expenses | 2,835,282 | 2,642,161 | 2,509,970 | 2,410,414 | 5,197,888 |
Operating Income | 408,884 | 127,011 | 518,538 | 149,578 | 483,772 |
Interest Expense | -173,622 | -132,246 | -134,034 | -68,883 | -14,227 |
Earnings From Equity Investments | -2,478 | 5,558 | 616 | -29,866 | 22,007 |
Currency Exchange Gain (Loss) | 101,493 | 609,922 | 161,516 | 423,276 | 522,142 |
Other Non Operating Income (Expenses) | -24,027 | -2,015 | 11,356 | 3,176 | -4,053 |
EBT Excluding Unusual Items | 310,250 | 608,230 | 557,992 | 477,281 | 1,009,641 |
Gain (Loss) on Sale of Investments | -137,943 | -236,629 | -251,768 | -494,973 | -659,531 |
Gain (Loss) on Sale of Assets | 3,121 | -547 | 1,435 | -546 | 175 |
Pretax Income | 175,428 | 371,054 | 307,659 | -18,239 | 350,285 |
Income Tax Expense | 50,934 | 56,761 | 67,833 | -6,880 | 74,666 |
Earnings From Continuing Ops. | 124,494 | 314,293 | 239,826 | -11,359 | 275,619 |
Net Income | 124,494 | 314,293 | 239,826 | -11,359 | 275,619 |
Net Income to Common | 124,494 | 314,293 | 239,826 | -11,359 | 275,619 |
Net Income Growth | -60.39% | 31.05% | - | - | 129.57% |
Shares Outstanding (Basic) | 156 | 156 | 156 | 156 | 156 |
Shares Outstanding (Diluted) | 156 | 156 | 156 | 156 | 156 |
Shares Change (YoY) | 0.07% | 0.03% | 0.02% | - | - |
EPS (Basic) | 797.76 | 2015.48 | 1538.47 | -72.88 | 1768.39 |
EPS (Diluted) | 797.76 | 2015.48 | 1538.47 | -72.88 | 1768.39 |
EPS Growth | -60.42% | 31.00% | - | - | 129.57% |
Free Cash Flow | 2,638,930 | -398,597 | 1,044,277 | -357,864 | 1,013,391 |
Free Cash Flow Per Share | 16910.24 | -2556.10 | 6698.98 | -2296.08 | 6501.99 |
Operating Margin | 12.60% | 4.59% | 17.12% | 5.84% | 8.52% |
Profit Margin | 3.84% | 11.35% | 7.92% | -0.44% | 4.85% |
Free Cash Flow Margin | 81.34% | -14.39% | 34.48% | -13.98% | 17.84% |
EBITDA | 437,809 | 154,352 | 541,550 | 172,389 | 505,478 |
EBITDA Margin | 13.49% | 5.57% | 17.88% | 6.73% | 8.90% |
D&A For EBITDA | 28,925 | 27,341 | 23,012 | 22,811 | 21,706 |
EBIT | 408,884 | 127,011 | 518,538 | 149,578 | 483,772 |
EBIT Margin | 12.60% | 4.59% | 17.12% | 5.84% | 8.52% |
Effective Tax Rate | 29.03% | 15.30% | 22.05% | - | 21.32% |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.